More articles from Research Articles: Therapeutics, Targets, and Development

WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G₁ arrest and growth inhibition of human invasive urinary bladder cancer cells
Yaxiong Tang, Anne R. Simoneau, Wu-xiang Liao, Guo Yi, Christopher Hope, Feng Liu, Shunqiang Li, Jun Xie, Randall F. Holcombe, Frances A. Jurnak, Dan Mercola, Bang H. Hoang, Xiaolin Zi

Molecular Cancer Therapeutics Feb 2009, 8 (2) 458-468; DOI: 10.1158/1535-7163.MCT-08-0885
Inhibition of cervical cancer cell growth by human papillomavirus virus–like particles packaged with human papillomavirus oncoprotein short hairpin RNAs
Latifa Bousarghin, Antoine Touze, Guillaume Gaud, Sophie Iochmann, Eva Alvarez, Pascale Reverdiau, Julien Gaitan, Marie-Lise Jourdan, Pierre-Yves Sizaret, Pierre L. Coursaget

Molecular Cancer Therapeutics Feb 2009, 8 (2) 357-365; DOI: 10.1158/1535-7163.MCT-08-0626
Mechanisms involved in synergistic anticancer effects of anti-4-1BB and cyclophosphamide therapy
Young H. Kim, Beom K. Choi, Ho S. Oh, Woo J. Kang, Robert S. Mittler, Byoung S. Kwon

Molecular Cancer Therapeutics Feb 2009, 8 (2) 469-478; DOI: 10.1158/1535-7163.MCT-08-0993
Dihydroorotate dehydrogenase inhibitor A771726 (leflunomide) induces apoptosis and diminishes proliferation of multiple myeloma cells
Philipp Baumann, Sonja Mandl-Weber, Andreas Völkl, Christian Adam, Irmgard Bumeder, Fuat Oduncu, Ralf Schmidmaier

Molecular Cancer Therapeutics Feb 2009, 8 (2) 366-375; DOI: 10.1158/1535-7163.MCT-08-0664
Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapy
Yunqing Li, Fadila Guessous, Charles DiPierro, Ying Zhang, Tucker Mudrick, Lauren Fuller, Elizabeth Johnson, Lukasz Marcinkiewicz, Matthew Engelhardt, Benjamin Kefas, David Schiff, Jin Kim, Roger Abounader

Molecular Cancer Therapeutics Feb 2009, 8 (2) 376-385; DOI: 10.1158/1535-7163.MCT-08-0627
Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells
Gary L. Gallia, Betty M. Tyler, Christine L. Hann, I-Mei Siu, Vincent L. Giranda, Angelo L. Vescovi, Henry Brem, Gregory J. Riggins

Molecular Cancer Therapeutics Feb 2009, 8 (2) 386-393; DOI: 10.1158/1535-7163.MCT-08-0680
Dasatinib-induced autophagy is enhanced in combination with temozolomide in glioma
Vanessa Milano, Yuji Piao, Tiffany LaFortune, John de Groot

Molecular Cancer Therapeutics Feb 2009, 8 (2) 394-406; DOI: 10.1158/1535-7163.MCT-08-0669
Effective sensitization of temozolomide by ABT-888 is lost with development of temozolomide resistance in glioblastoma xenograft lines
Michelle J. Clarke, Evan A. Mulligan, Patrick T. Grogan, Ann C. Mladek, Brett L. Carlson, Mark A. Schroeder, Nicola J. Curtin, Zhenkun Lou, Paul A. Decker, Wenting Wu, E. Ruth Plummer, Jann N. Sarkaria

Molecular Cancer Therapeutics Feb 2009, 8 (2) 407-414; DOI: 10.1158/1535-7163.MCT-08-0854
Effect of hypoxia on the expression of phosphoglycerate kinase and antitumor activity of troxacitabine and gemcitabine in non-small cell lung carcinoma
Wing Lam, Scott Bussom, Yung-Chi Cheng

Molecular Cancer Therapeutics Feb 2009, 8 (2) 415-423; DOI: 10.1158/1535-7163.MCT-08-0692
Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells
Cristina Morales, Maria J. García, Maria Ribas, Rosa Miró, Mar Muñoz, Carlos Caldas, Miguel A. Peinado

Molecular Cancer Therapeutics Feb 2009, 8 (2) 424-432; DOI: 10.1158/1535-7163.MCT-08-0759

Main menu

User menu

Search

More articles from Research Articles: Therapeutics, Targets, and Development

Pages

Articles

Info for

About MCT